H2 TEXT FOR SEARCH ENGINES
Today's Most Advanced Approaches for Identifying and Reversing Patients' Cardiovascular Disease
Boston Heart collaborates with you to predict, prevent, manage and reverse cardiovascular disease (CVD) among your patients.
Beyond our advanced testing, we give you vital information about each patient through plans that contain individualized recommendations for treatment, as well as lifestyle changes that are realistic and achievable. We support your patient with science-based lifestyle improvement tools that help patients adhere to their treatment plans and complete the continuum of care.
Read about our innovative tools for disease management and patient care:
Boston Heart’s reports go far beyond reporting results. Our reports also offer interpretations that can help you with your diagnosis and treatment decisions.
Our lab results, interpretations and recommendations are presented in an easy-to-read format. We offer succinct clinical recommendations to help you streamline patient care and communicate more effectively with your patients.
When you order testing from Boston Heart, we also provide you with a personalized Diagnostic Report for your patients.
We create each patient's personalized Diagnostic Report using our proprietary cardio-informatics system. This system uses an algorithm to integrate all test results and individual clinical factors with scientific lipidology findings and clinical parameters, and then generates an evidence-based, guideline-driven risk assessment specific to each patient.
The Diagnostic Report contains detailed treatment recommendations, covering modification of diet and lifestyle, and drug and supplement therapies. Results and recommendations are explained in clear language so patients can understand and take action.
Medication cannot cure CVD. However, patient lifestyle improvements, particularly in the areas of diet and exercise, are proven to benefit heart health and can help to reverse CVD and diabetes.
The Boston Heart Lifestyle Program integrates the results of a patient’s advanced lipid testing and CVD risk assessment with science-based recommendations for diet, exercise and other lifestyle modifications. The patient pursues these personally meaningful goals with the help of a coach—a Registered Dietitian who blends information and motivation to drive success. Additional resources in this program help you monitor each patient's progress.
Our approach draws on original dietary studies by nationally renowned nutrition, weight loss and diabetes-reversal experts Dr. Michael Dansinger, MD; Ernst Schaefer, MD; and Joi Gleason, MS, RD, LDN. We combine this knowledge with national nutrition guidelines for managing cholesterol and blood pressure, to create a highly effective solution.
When you advise your patients to enroll in our Lifestyle Program, we generate a personalized Life Plan, derived from a unique algorithm that provides a scientifically-designed eating strategy for each patient to reduce his or her CVD risk. The plan combines individual test results and risk factors with evidence-based dietary modifications that are personalized to their preferences, and will help your patients experience progress and stay motivated.
Lifestyle coaching is a key element of this program. Boston Heart's trained team of Registered Dietitians supports your patients with lifestyle coaching by phone. This dynamic, one-on-one personal connection has been shown to make long-term lifestyle changes more achievable.
Our Lifestyle Program supports your follow-up care with tools specifically designed to help you engage your patients—so that you can improve their health outcomes. The program is integrated with easy-to-use tools, including an online and smartphone accessible food and exercise tracker and motivational tips from coaches, to help your patients stay on track and in sync with your treatment guidance.
1. Myers, J. Exercise and Cardiovascular Health. Circulation. 2003;107: e2–e5.
2. Cannon CP, Braunwald E, McCabe CH, et al; for The Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–1504.
3. LaRosa JC, Grundy SM, Waters DD, et al; for the Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425–1435.
4. Pedersen TR, Faergeman O, Kastelein JJP, et al; for the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL Study: A randomized controlled trial. JAMA. 2005;294:2437–2445.
5. Roger VL, Go AS, Lloyd-Jones DM, et al; for The American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics —2011 Update: A Report from the American Heart Association. Circulation. 2011;123:e18–e209.
- Want to learn more?
- Did you know?
- A sedentary lifestyle is one of the five major risk factors for cardiovascular disease (along with high blood pressure, abnormal values for blood lipids, smoking, and obesity), as outlined by the AHA.1
- Recent research shows that following current cholesterol treatment guidelines reduces a patient’s risk for cardiovascular events by only 25%--this means standard therapy fails to address 75% of a patient’s residual risk for CVD events.2,3,4
- CVD claims more lives each year than cancer, chronic lower respiratory disease and accidents combined.5
- Test Menu
- For a complete listing and description of tests performed in our laboratory, see our Test Menu.